Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2020-08-26 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
第四届董事会第二十四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board meeting of Tianjin Ruipu Biotechnology Co., Ltd. It includes approvals of the 2020 semi-annual report and related summary, adjustments to stock incentive plans, approval of related party transactions, amendments to company bylaws, and notices of upcoming shareholder meetings. The document references multiple agenda items and voting results from the board meeting, indicating it is a Board/Management Information announcement. It is not the full semi-annual report itself but a board meeting resolution announcement. The document length is about 5,025 characters, which is consistent with a detailed board meeting announcement rather than a full financial report. Therefore, the appropriate classification is MANG (Board/Management Information).
2020-08-26 Chinese
东莞证券股份有限公司关于公司使用部分超募资金永久性补充流动资金的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed special verification opinion report by Dongguan Securities, the sponsor institution, regarding Tianjin Ruipu Biotechnology Co., Ltd.'s use of part of the over-raised funds to permanently supplement working capital. It includes extensive information on the original fundraising, fund management, usage, approvals by the board and supervisory committee, independent directors' opinions, and sponsor institution's verification. The document references regulatory guidelines and compliance with securities laws. It is not a general annual or interim report, nor an earnings release or call transcript. It is a specialized audit/verification report focused on the use of raised funds, specifically over-raised funds, and their compliance with regulations. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit/verification report related to accounting and regulatory compliance, not a full annual report or other category. The document length and content confirm it is the report itself, not just an announcement or certification letter. H1 2020
2020-08-26 Chinese
北京市康达律师事务所关于公司回购注销部分限制性股票相关事项之法律意见书
Transaction in Own Shares Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the repurchase and cancellation of certain restricted shares under a stock incentive plan by Tianjin Ruipu Biotechnology Co., Ltd. It details the legal compliance, approval processes, reasons, quantities, prices, and funding sources for the repurchase and cancellation of restricted stock. The document is not a financial report, earnings release, or management discussion, but a legal opinion related to a specific corporate action involving share repurchase and cancellation. This fits best under the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares, including repurchase and cancellation of restricted stock. The document is substantive and not merely an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA).
2020-08-26 Chinese
监事会议事规则
Governance Information Classification · 95% confidence The document is titled as the "监事会议事规则" which translates to "Supervisory Board Meeting Rules" for Tianjin Ringpu Bio-technology Co., Ltd. It details the rules, structure, duties, meeting procedures, and responsibilities of the supervisory board (监事会) within the company. There are no financial statements, earnings data, or report summaries present. The document is a governance-related internal rules document describing board structure and procedures, not a financial report or announcement. It does not announce any voting results, dividends, or management changes. It is not a call transcript or legal proceeding update. The content fits the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices. The document length is over 5,000 characters and contains substantive governance content, not just an announcement or certification. Therefore, the correct classification is CGR with high confidence.
2020-08-26 Chinese
关联交易决策制度
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled '关联交易决策制度' (Related Party Transaction Decision System) issued by Tianjin Ringpu Bio-technology Co., Ltd. It outlines the principles, definitions, decision procedures, disclosure requirements, and exemptions related to related party transactions. It references relevant laws and stock exchange rules, and includes procedural and governance details about how related party transactions should be handled, approved, and disclosed. There is no indication that this is a financial report, earnings release, or any form of regulatory filing announcing results or changes. Instead, it is a governance document detailing internal rules and procedures related to corporate governance and compliance with related party transaction regulations. Therefore, the most appropriate classification is Governance Information (CGR). The document length (7159 characters) and content confirm it is a substantive governance policy document, not a brief announcement or certification.
2020-08-26 Chinese
对外担保管理制度
Governance Information Classification · 95% confidence The document is titled as a management system for external guarantees by Tianjin Ringpu Bio-technology Co., Ltd. It extensively details the company's policies, procedures, responsibilities, and governance related to providing guarantees to third parties. The content includes references to relevant laws, company bylaws, approval processes by the board and shareholders, risk management, disclosure obligations, and responsibilities of company officers. There is no indication that this is a financial report, audit report, earnings release, or any other financial statement. Instead, it is a governance and management policy document related to external guarantees. This fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length (8320 characters) and detailed procedural content support this classification with high confidence.
2020-08-26 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.